AG
ABMD

Algert Global’s Abiomed Inc ABMD Stock Holding History

Algert Global’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,363
Closed -$1.07M – 1336
2022
Q3 		$1.07M Sell
4,363
-340
-7% -$91.8K 0.06% 511
2022
Q2 		$1.16M Buy
4,703
+705
+18% +$190K 0.09% 407
2022
Q1 		$1.32M Buy
+3,998
New +$1.23M 0.09% 394
2019
Q2 		– Sell
-1,800
Closed -$514K – 418
2019
Q1 		$514K Sell
1,800
-1,080
-38% -$359K 0.29% 127
2018
Q4 		$936K Buy
+2,880
New +$1M 0.26% 132

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Algert Global's ABMD Position: Q4 2022 in Review

Algert Global sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 4,363 shares — an estimated $1.07M sold.

Algert Global first reported a position in ABMD in Q4 2018 and held it in 5 quarters. The position peaked at $1.32M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Algert Global reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Algert Global sold 4,363 Abiomed Inc shares in Q4 2022, an estimated $1.07M.
  • Algert Global first reported a position in Abiomed Inc in Q4 2018 and held it in 5 quarters.
  • Algert Global's Abiomed Inc position peaked at $1.32M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Algert Global's 13F filing for Q4 2022, filed 14 Feb 2023.